National Adult and Influenza
Immunization Summit
Home | National Influenza Vaccine Summit | For Healthcare Professionals | For the Public
 
 Healthcare Professionals  
 HCP Home
 Influenza Disease
 Later Season Vaccination
 Recommendations
 Special Populations
 Vaccine Pocket Guides
 Vaccine Production
 Vaccination Resources
 Vaccinating HCWs
Order free laminated Influenza Pocket Guides for front-line healthcare providers.

UPenn Fights Influenza:
Baby, Be Wise -- Immunize!

Using song and lyrics to raise awareness of the importance of influenza vaccination for HCWs, the Hospital of the University of Pennsylvania created this 5-minute video featuring scores of employees lip-synching to a doo-wop beat.
Information for Healthcare Professionals
Influenza - prevent a bad disease with a good vaccine!
Vaccine Production, Ordering, and Distribution
Seasonal Influenza Vaccines for the 2013-2014 Season
Manufacturer Trade Name
(vaccine abbreviation)1
How Supplied Mercury
Content
(μg Hg/0.5mL)
Age Group Product
Code
CSL Limited Afluria (IIV3) 0.5 mL (single-dose syringe) 0 9 years & older2 90656
5.0 mL (multi-dose vial) 24.5 90658
Q2035
(Medicare)
GlaxoSmithKline Fluarix (IIV3) 0.5 mL (single-dose syringe) 0 3 years & older 90656
Fluarix (IIV4) 0.5 mL (single-dose syringe) 0 3 years & older 90686
ID Biomedical Corp. of Quebec,
a subsidiary of GlaxoSmithKline
FluLaval (IIV3) 5.0 mL (multi-dose vial) <25 3 years & older 90658
Q2036
(Medicare)
FluLaval (IIV4) 5.0 mL (multi-dose vial) <25 3 years & older 90688
MedImmune FluMist (LAIV4) 0.2 mL (single-use nasal spray) 0 2 through 49 years 90672
Novartis Vaccines Fluvirin (IIV3) 0.5 mL (single-dose syringe) <1 4 years and older 90656
5.0 mL (multi-dose vial) 25 90658
Q2037
(Medicare)
Flucelvax (ccIIV3) 0.5 mL (single-dose syringe) 0 18 years & older 90661
Protein Sciences Corp. Flublok (RIV3) 0.5 mL (single-dose vial) 0 18 through 49 years 90673
Q2033
(Medicare)
sanofi pasteur Fluzone (IIV3) 0.25 mL (single-dose syringe) 0 6 through 35 months 90655
0.5 mL (single-dose syringe) 0 3 years & older 90656
0.5 mL (single-dose vial) 0 3 years & older 90656
5.0 mL (multi-dose vial) 25 6 through 35 months 90657
5.0 mL (multi-dose vial) 25 3 years & older 90658
Q2038
(Medicare)
Fluzone (IIV4) 0.25 mL (single-dose syringe) 0 6 through 35 months 90685
0.5 mL (single-dose syringe) 0 3 years & older 90686
0.5 mL (single-dose vial) 0 3 years & older 90686
Fluzone High-Dose (IIV3) 0.5 mL (single-dose syringe) 0 65 years & older 90662
Fluzone Intradermal (IIV3) 0.1 mL (single-dose microinjection system) 0 18 through 64 years 90654
Footnotes
1. IIV3 = egg-based and cell culture-based trivalent inactivated influenza vaccine (injectable); where necessary to refer to cell culture-based vaccine, the prefix "cc" is used (e.g., ccIIV3). IIV4 = egg-based quadrivalent inactivated influenza vaccine (injectable); LAIV4 = egg-based quadrivalent live attenuated influenza vaccine (nasal spray); RIV3 = trivalent recombinant hemagglutinin influenza vaccine (injectable).
2. On August 6, 2010, ACIP recommended that Afluria not be used in children younger than age 9 years. If no other age-appropriate IIV is available, Afluria may be considered for a child age 5 through 8 years at high risk for influenza complications, after risks and benefits have been discussed with the parent or guardian. Afluria should not be used in children younger than age 5 years. This recommendation continues for the 20132014 influenza season.
Seasonal Influenza Vaccine Ordering
Most providers order influenza vaccine for the coming vaccination season in the winter and spring of the preceding year. Depending on many factors, orders can be placed direct with the manufacturer, with a distributor, the state's VFC program, or a group purchasing arrangement. The National Influenza Vaccine Summit also operates a voluntary vaccine tracking system that enables healthcare providers to view at a glance which distributors have vaccine available to sell. To view vaccine currently for sale on the Summit's Influenza Vaccine Availability Tracking System, known as IVATS, click here.

Interested in Learning More About Influenza Vaccine Production?
Read a report from the Health Industry Distributors Association, a non-profit trade association of medical products distributors who service healthcare providers, that explains the process that determines when and how vaccine reaches doctors, hospitals, nursing homes, and others.

Understanding the Dynamics of Influenza Vaccine Supply and Demand -- Five Issue Briefs. This series of briefs were prepared for the Assistant Secretary for Planning and Evaluation of the Department of Health and Human Services in October 2005.

Overview -- Summary and Assessment: roles and responsibilities of the influenza vaccine stakeholders.
 
Vaccine Economics: characteristics of the influenza vaccine market, industry regulatory requirements for vaccine productions, and factors affecting the profitability of vaccine production.


Who Buys It and Who Sells It: the vaccine supply chain and potential means for facilitating vaccine purchase and distribution.


Vaccine Manufacturing: the unique characteristics of the influenza vaccine, the structure of the industry, decisions about the amount of vaccine produced each year, investments in new technologies, and other factors.

The Chicken and the Egg: factors that impact the demand for vaccine and how they can affect supply.
 
Immunization Action Coalition  |  Litjen (L.J) Tan lj.tan@immunize.org  |   1573 Selby Ave - Suite 234  |  St. Paul MN 55104
Site managed by the Immunization Action Coalition  |  Laurel Wood, MPA, editor  |  Mitch Rothholtz, RPh, MBA, contributing editor